{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T08:13:10Z","timestamp":1762848790032,"version":"build-2065373602"},"reference-count":44,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2025.12985","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T11:44:46Z","timestamp":1759146286000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric diffuse low\u2011grade glioma with oligodendroglioma\u2011like features: A case report"],"prefix":"10.3892","volume":"30","author":[{"given":"Pengwei","family":"Hou","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Shanghai Sixth People's Hospital Fujian, Jinjiang, Fujian 362200, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengzhu","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Shanghai Sixth People's Hospital Fujian, Jinjiang, Fujian 362200, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian 350025, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xieli","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Shanghai Sixth People's Hospital Fujian, Jinjiang, Fujian 362200, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingfa","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Shanghai Sixth People's Hospital Fujian, Jinjiang, Fujian 362200, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"key20251111101007_b1-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00428-017-2181-4","article-title":"Characterization of gliomas: From morphology to molecules","volume":"471","author":"Ferris","year":"2017","journal-title":"Virchows Arch"},{"key":"key20251111101007_b2-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: A summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"key20251111101007_b3-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.4103\/ijpm.ijpm_1043_21","article-title":"Pediatric-type diffuse low grade gliomas: Histomolecular profile and practical approach to their integrated diagnosis according to the WHO CNS5 classification","volume":"65 (Suppl)","author":"Purkait","year":"2022","journal-title":"Indian J Pathol Microbiol"},{"key":"key20251111101007_b4-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"665","DOI":"10.25122\/jml-2023-0515","article-title":"Recent updates in pediatric diffuse glioma classification: Insights and conclusions from the WHO 5th edition","volume":"17","author":"Patel","year":"2024","journal-title":"J Med Life"},{"key":"key20251111101007_b5-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00381-016-3163-6","article-title":"An integrative molecular and genomic analysis of pediatric hemispheric low-grade gliomas: An update","volume":"32","author":"Lassaletta","year":"2016","journal-title":"Childs Nerv Syst"},{"key":"key20251111101007_b6-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00401-019-01987-0","article-title":"cIMPACT-NOW update 4: Diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation","volume":"137","author":"Ellison","year":"2019","journal-title":"Acta Neuropathol"},{"key":"key20251111101007_b7-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/jnen\/nlac123","article-title":"MYB\/MYBL1::QKI fusion-positive diffuse glioma","volume":"82","author":"Suh","year":"2023","journal-title":"J Neuropathol Exp Neurol"},{"key":"key20251111101007_b8-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0140-6736(74)91639-0","article-title":"Assessment of coma and impaired consciousness. A practical scale","volume":"2","author":"Teasdale","year":"1974","journal-title":"Lancet"},{"key":"key20251111101007_b9-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/B978-0-12-802997-8.00023-2","article-title":"Glioblastoma","volume":"134","author":"Wirsching","year":"2016","journal-title":"Handb Clin Neurol"},{"issue":"236","key":"key20251111101007_b10-ETM-30-6-12985","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2023.11935","article-title":"Lateral ventricle chordoid meningioma presenting with inflammatory syndrome in an adult male: A case report","volume":"25","author":"Hu","year":"2023","journal-title":"Exp Ther Med"},{"key":"key20251111101007_b11-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.nec.2018.09.001","article-title":"Diffuse low-grade glioma-related epilepsy","volume":"30","author":"Pallud","year":"2019","journal-title":"Neurosurg Clin N Am"},{"key":"key20251111101007_b12-ETM-30-6-12985"},{"key":"key20251111101007_b13-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/978-3-7091-6513-3_13","article-title":"Low grade glioma in intractable epilepsy: Lesionectomy versus epilepsy surgery","volume":"68","author":"Lombardi","year":"1997","journal-title":"Acta Neurochir Suppl"},{"key":"key20251111101007_b14-ETM-30-6-12985","first-page":"294","article-title":"Observations on the physiology and pathology of hemi-chorea","volume":"14","author":"Hughlings-Jackson","year":"1869","journal-title":"Edinb Med J"},{"key":"key20251111101007_b15-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1046\/j.1528-1157.2003.56102.x","article-title":"The spectrum of long-term epilepsy-associated tumors: Long-term seizure and tumor outcome and neurosurgical aspects","volume":"44","author":"Luyken","year":"2003","journal-title":"Epilepsia"},{"key":"key20251111101007_b16-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1750-3639.2012.00582.x","article-title":"Long-term epilepsy-associated tumors","volume":"22","author":"Thom","year":"2012","journal-title":"Brain Pathol"},{"key":"key20251111101007_b17-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1007\/s00381-024-06468-8","article-title":"Low-grade glioma of the temporal lobe and tumor-related epilepsy in children","volume":"40","author":"Baticulon","year":"2024","journal-title":"Childs Nerv Syst"},{"key":"key20251111101007_b18-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"e761","DOI":"10.1016\/j.wneu.2018.09.212","article-title":"CD34 expression in low-grade epilepsy-associated tumors: Relationships with clinicopathologic features","volume":"121","author":"Giulioni","year":"2019","journal-title":"World Neurosurg"},{"key":"key20251111101007_b19-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-016-1639-9","article-title":"Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): An epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway","volume":"133","author":"Huse","year":"2017","journal-title":"Acta Neuropathol"},{"key":"key20251111101007_b20-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","article-title":"Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma","volume":"121","author":"Schindler","year":"2011","journal-title":"Acta Neuropathol"},{"key":"key20251111101007_b21-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1007\/s12035-017-0599-y","article-title":"BRAF mutation is associated with an improved survival in glioma-a systematic review and meta-analysis","volume":"55","author":"Vuong","year":"2018","journal-title":"Mol Neurobiol"},{"key":"key20251111101007_b22-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"key20251111101007_b23-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5414\/NP301609","article-title":"Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): A case report with surgical and neuropathological differential diagnosis","volume":"43","author":"Orhan","year":"2024","journal-title":"Clin Neuropathol"},{"key":"key20251111101007_b24-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/jnen\/nlz101","article-title":"Genomic analysis of dysembryoplastic neuroepithelial tumor spectrum reveals a diversity of molecular alterations dysregulating the MAPK and PI3K\/mTOR pathways","volume":"78","author":"Surrey","year":"2019","journal-title":"J Neuropathol Exp Neurol"},{"key":"key20251111101007_b25-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ccell.2020.03.011","article-title":"Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas","volume":"37","author":"Ryall","year":"2020","journal-title":"Cancer Cell"},{"key":"key20251111101007_b26-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00401-018-1874-3","article-title":"Pediatric low-grade gliomas can be molecularly stratified for risk","volume":"136","author":"Yang","year":"2018","journal-title":"Acta Neuropathol"},{"key":"key20251111101007_b27-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/ng.2611","article-title":"Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas","volume":"45","author":"Zhang","year":"2013","journal-title":"Nat Genet"},{"key":"key20251111101007_b28-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/ng.2682","article-title":"Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma","volume":"45","author":"Jones","year":"2013","journal-title":"Nat Genet"},{"key":"key20251111101007_b29-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/ng.3500","article-title":"MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism","volume":"48","author":"Bandopadhayay","year":"2016","journal-title":"Nat Genet"},{"issue":"100857","key":"key20251111101007_b30-ETM-30-6-12985","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2022.100857","article-title":"Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era","volume":"36","author":"Manoharan","year":"2023","journal-title":"Neoplasia"},{"key":"key20251111101007_b31-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00401-016-1549-x","article-title":"Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors","volume":"131","author":"Rivera","year":"2016","journal-title":"Acta Neuropathol"},{"key":"key20251111101007_b32-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00401-016-1539-z","article-title":"Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology","volume":"131","author":"Qaddoumi","year":"2016","journal-title":"Acta Neuropathol"},{"key":"key20251111101007_b33-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/neuonc\/noac132","article-title":"Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics","volume":"25","author":"Yeo","year":"2023","journal-title":"Neuro Oncol"},{"issue":"e13060","key":"key20251111101007_b34-ETM-30-6-12985","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13060","article-title":"The 2021 WHO classification of tumors of the central nervous system: An update on pediatric low-grade gliomas and glioneuronal tumors","volume":"32","author":"Bale","year":"2022","journal-title":"Brain Pathol"},{"key":"key20251111101007_b35-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.2147\/OTT.S182721","article-title":"Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US food and drug administration-approved targeted therapy in advanced melanoma","volume":"11","author":"Kakadia","year":"2018","journal-title":"Onco Targets Ther"},{"key":"key20251111101007_b36-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.18632\/oncotarget.27600","article-title":"Phase I study of vemurafenib in children with recurrent or progressive BRAFV600E mutant brain tumors: Pacific pediatric neuro-oncology consortium study (PNOC-002)","volume":"11","author":"Nicolaides","year":"2020","journal-title":"Oncotarget"},{"key":"key20251111101007_b37-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1093\/neuonc\/noaa071","article-title":"A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: A neurofibromatosis clinical trials consortium study","volume":"22","author":"Ullrich","year":"2020","journal-title":"Neuro Oncol"},{"key":"key20251111101007_b38-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"key20251111101007_b39-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov"},{"issue":"112197","key":"key20251111101007_b40-ETM-30-6-12985","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112197","article-title":"Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma","volume":"42","author":"Rajendran","year":"2023","journal-title":"Cell Rep"},{"key":"key20251111101007_b41-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","article-title":"Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas","volume":"68","author":"Jones","year":"2008","journal-title":"Cancer Res"},{"key":"key20251111101007_b42-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1073\/pnas.1219232110","article-title":"Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas","volume":"110","author":"Sievert","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20251111101007_b43-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/jcph.1617","article-title":"Population pharmacokinetics of vemurafenib in children with recurrent\/refractory BRAF gene V600E-mutant astrocytomas","volume":"60","author":"Wang","year":"2020","journal-title":"J Clin Pharmacol"},{"key":"key20251111101007_b44-ETM-30-6-12985","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1470-2045(21)00578-7","article-title":"Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): A multicentre, open-label, single-arm, phase 2, basket trial","volume":"23","author":"Wen","year":"2022","journal-title":"Lancet Oncol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T08:10:11Z","timestamp":1762848611000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2025.12985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,9,29]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2025.12985","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"type":"print","value":"1792-0981"},{"type":"electronic","value":"1792-1015"}],"subject":[],"published":{"date-parts":[[2025,9,29]]}}}